Luis Augusto Palma Dallan, MD
Cardiology · Cleveland, OHNPI 1124631114
Payments from drug & device makers
What this record shows
This record is dominated by grants: $43,000 of the $61,102 with a category attached, or 70.4%. Medtronic accounts for 88.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $24,334 and has fallen 90.6% since, to $2,283 in 2025. Among cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $265.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$54K
- Boston Scientific$2K
- Edwards Lifesciences$2K
- Abbott$1K
- Shockwave Medical, Inc$441
- Abiomed$413
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$6,60011%
- Grants$43,00070%
- Travel & lodging$1,6633%
- Food & beverage$9,57016%
- Education$2680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 114 | $53,869 |
| Boston Scientific | 24 | $1,974 |
| Edwards Lifesciences | 13 | $1,570 |
| Abbott | 13 | $1,432 |
| Shockwave Medical, Inc | 9 | $441 |
| Abiomed | 6 | $413 |
| Cardiva Medical, Inc. | 3 | $330 |
| Inari Medical, Inc. | 1 | $152 |
| Pfizer | 8 | $138 |
| AstraZeneca(2 entities) | 7 | $126 |
| Atricure, Inc. | 6 | $123 |
| Amgen | 7 | $123 |
| Novartis | 3 | $77 |
| Terumo Medical Corporation | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Boehringer Ingelheim | 3 | $49 |
| Stryker | 1 | $43 |
| Novo Nordisk | 2 | $36 |
| Lantheus Medical Imaging, Inc. | 1 | $30 |
| Merck | 1 | $22 |
| Johnson & Johnson | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONYX FRONTIER$7,636
- COREVALVE EVOLUT R$707
- WATCHMAN FLX$517
- DRAGONFLY OPSTAR$331
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$313
- Diamondback Coronary$307
- WATCHMAN Access System$291
- MitraClip$274
- RESOLUTE ONYX$249
- PRESSUREWIRE$182
- GENERAL - THERAPIES$165
- FLOWTRIEVER CATHETER, S$152
- CT THROMBECTOMY SYSTEM KIT$152
- CoreValve Evolut$145
- Resolute$144
- ESPRIT$141
- Impella$132
- Cardiva VASCADE MVP VVCS 6-12F$131
- Octopus$129
- OPTIS$126
How this compares
$61,102 in reported general payments places this provider in the 95th percentile of 30 cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 64 | $66,399 |
| JardianceEmpagliflozin | 24 | $34,178 |
| XareltoRivaroxaban | 29 | $28,591 |
| EntrestoSacubitril/Valsartan | 22 | $24,459 |
| Metoprolol Succinate | 405 | $3,467 |
| Atorvastatin Calcium | 258 | $2,083 |
| Hydralazine Hcl | 24 | $702 |
| ClopidogrelClopidogrel Bisulfate | 77 | $655 |
| Potassium Chloride | 13 | $593 |
| Ezetimibe | 34 | $586 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 36 | $413 |
| Losartan Potassium | 58 | $360 |
| Lisinopril | 91 | $329 |
| Metoprolol Tartrate | 75 | $315 |
| Rosuvastatin Calcium | 51 | $313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $138 | $66,39964 claims |
| Boehringer IngelheimJardiance | $49 | $34,17824 claims |
| Johnson & JohnsonXarelto | $17 | $28,59129 claims |
| NovartisEntresto | $77 | $24,45922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 30 cardiology providers in Ohio.
Other cardiology in Cleveland
- Haytham MouslyCleveland$17K
- Robert OkyereCleveland$102
- Ajay BhargavaCleveland$0
- Karen KutoloskiCleveland$0
- Tamanna SinghCleveland$0
- Curtis RimmermanCleveland$0
- Maran ThamilarasanCleveland$0
- Patrick HughesCleveland$0
- Robert FinkelhorCleveland$0
- Donald HammerCleveland$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.